FOR REMOTE PATIENT MONITORING
RESP® Biosensor
Manage lung health from hospital to home with objective monitoring of symptoms
FDA 510(k) Class II | CE Mark | HIPAA Compliant

Technology Overview
Developed by an asthma patient, the RESP® Biosensor offers clinicians and healthcare teams a novel approach to improve disease surveillance with at-risk patients.
- Continuous lung sound monitoring: High-fidelity wearable device continuously captures lung sounds to extend the range of stethoscope auscultation.
- Patient-friendly device: Wireless, discreet design that respects patient comfort and lifestyle.
- Clinically validated: Demonstrated reliability, accuracy, and ease of use in several patient populations. View publications

OVERVIEW VIDEO
“With this information we can predict if the patient is doing better or worse and intervene ahead of time to prevent the patient from having major complications”
– Sadia Benzaquen, MD, Chair of Pulmonary Critical Care, Einstein Medical Center
Track Patient Progress Objectively and Remotely
KEY FEATURES
- Passive & continuous
- Wireless & lightweight
- HIPAA compliant
- Reimbursable under RTM & RPM codes
- 24+ hour battery life
- Rechargeable
- EHR/telehealth integration
- Proprietary machine learning algorithms* for event detection
*Machine learning algorithms not FDA cleared
Lung sound recordings captured by the biosensor are depicted visually as spectrograms
Cough
Wheeze
Crackles
Actively Seeking Research Collaborations
We’re actively seeking clinical and academic collaborators to expand the evidence base for objective cough and lung sound monitoring. Partners may be eligible for in-kind support.
RESP® Biosensor Care Settings
Ambulatory Care
- Remote monitoring of at-risk COPD & Asthma patients
- Interstitial lung diseases
- Heart failure
- Pulmonary Rehabilitation
Acute Care
- In-patient status monitoring
- Chronic, complex care management
- Hospital at Home
- Tele-ICUs
Post-Acute Care
- Post-discharge hospital to home
- Post-surgical recovery and rehabilitation
- Skilled-nursing and long-term care facilities
Practice Application
Patient is prescribed RESP® Biosensor for two weeks
On day 5, clinician receives alert of increased coughing and wheezing
Clinician checks in with patient virtually and adjusts treatment plan to avoid a readmission
Publications
View our clinical validation, whitepapers and case studies
Increasing Abnormal Lung Sounds After Discharge Predicts COPD Readmission
Poster Presentation, CHEST, 2023
Remote Auscultation At Home After Asthma Exacerbation: A Case from Discharge to Readmission
Poster Presentation, American Thoracic Society, 2020
Talk to our Team
Reach out to explore using the RESP Biosensor in your practice